Frequency and Phenotype of Infected Clones
Patient . | Virus . | Diagnosis . | Infected Clones/Total Clones . | Phenotype . | ||
---|---|---|---|---|---|---|
. | . | . | . | CD4 . | CD8 . | ND . |
Pr | HTLV-I | TSP | 8/24 (33%)* | — | — | 8 |
Du | HTLV-I | TSP | 7/40 (17%) | 5 | 1 | 1 |
Mu | HTLV-I | TSP | 4/20 (20%) | 4 | 0 | — |
Ph | HTLV-I | NSP | 1/9 (11%) | 0 | 1 | — |
CP | HTLV-I | polymyositis | 3/20 (15%) | 3 | 0 | — |
RM | HTLV-I | ASX | 1/30 (3%) | — | — | 1 |
RB | HTLV-II | ASX† | 0/162 (<1%) | — | — | — |
Patient . | Virus . | Diagnosis . | Infected Clones/Total Clones . | Phenotype . | ||
---|---|---|---|---|---|---|
. | . | . | . | CD4 . | CD8 . | ND . |
Pr | HTLV-I | TSP | 8/24 (33%)* | — | — | 8 |
Du | HTLV-I | TSP | 7/40 (17%) | 5 | 1 | 1 |
Mu | HTLV-I | TSP | 4/20 (20%) | 4 | 0 | — |
Ph | HTLV-I | NSP | 1/9 (11%) | 0 | 1 | — |
CP | HTLV-I | polymyositis | 3/20 (15%) | 3 | 0 | — |
RM | HTLV-I | ASX | 1/30 (3%) | — | — | 1 |
RB | HTLV-II | ASX† | 0/162 (<1%) | — | — | — |